SCHEMBL22154113

SCHEMBL22154113

N#Cc1c(-c2ccc(-n3c4ccccc4c4c(-n5c6ccccc6c6ccccc65)cccc43)cc2)cccc1-n1c2ccccc2c2c(C#N)cccc21

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ESR2 Q92731 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
PDE10A Q9Y233 1/20 0.32
PPARG P37231 2/20 0.31
PRKAG1 P54619 2/20 0.31
PRKAA1 Q13131 2/20 0.31
PRKAB1 Q9Y478 2/20 0.31
PDE9A O76083 1/20 0.31
PDE1C Q14123 1/20 0.31
NR3C1 P04150 1/20 0.30
IMPDH2 P12268 1/20 0.30
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22154098 1.00 SMN1; SMN2 (0.38) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22152909 0.93 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22153756 0.93 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22378522 0.93 SMN1; SMN2 (0.41) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22377799 0.93 SMN1; SMN2 (0.41) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22153280 0.92 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22154309 0.92 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22153943 0.92 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22152507 0.92 SMN1; SMN2 (0.36) SMN1; SMN2HIF1AKDM4EATML3MBTL1
SCHEMBL22378501 0.92 SMN1; SMN2 (0.35) SMN1; SMN2HIF1AKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 SMN1; SMN2 4714/4885HIF1A 1612/4885KDM4E 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.